Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis

NCT01885832 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped per sponsor decision

Conditions

Osteoarthritis

Interventions

BIOLOGICAL: Autologous adipose tissue stromal vascular fraction

Sponsor

Translational Biosciences